Zacks Company Profile for Surface Oncology, Inc. (SURF : NSDQ) |
|
|
|
Company Description |
Surface Oncology, Inc. is a clinical-stage immuno-oncology company. It develops therapies for the treatment of cancer. The company's product pipeline includes CD47, CD73, SRF231, SRF373, SRF617, SRF388 and SRF231 which are in clinical stage. Surface Oncology is based in Cambridge, Massachusetts.
Number of Employees: 60 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $0.76 |
Daily Weekly Monthly
 |
20 Day Moving Average: 235,364 shares |
Shares Outstanding: 60.72 (millions) |
Market Capitalization: $46.24 (millions) |
Beta: 1.68 |
52 Week High: $2.15 |
52 Week Low: $0.56 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
31.86% |
26.87% |
12 Week |
2.96% |
-4.42% |
Year To Date |
-7.13% |
-15.53% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Robert W. Ross - Chief Executive Officer
Denice Torres - Chairman of the Board
Jessica Fees - Chief Financial Officer
Carsten Brunn - Director
J. Jeffrey Goater - Director
|
|
Peer Information
Surface Oncology, Inc. (BJCT)
Surface Oncology, Inc. (CADMQ)
Surface Oncology, Inc. (APNO)
Surface Oncology, Inc. (UPDC)
Surface Oncology, Inc. (IMTIQ)
Surface Oncology, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 86877M209
SIC: 2836
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/23
Next Expected EPS Date: 08/02/23
|
|
Share - Related Items
Shares Outstanding: 60.72
Most Recent Split Date: (:1)
Beta: 1.68
Market Capitalization: $46.24 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $-0.34 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-1.37 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 3.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/02/23 |
|
|
|
|